Cost-effectiveness issues in ventilator-associated pneumonia

Respiratory Care

Volumn 50, Issue 7, 2005, Pages 956-963

  Solomkin, Joseph S ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Cost effectiveness; QALY; Quality adjusted life year; Ventilator associated pneumonia

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; METFORMIN; OMEPRAZOLE; TISSUE PLASMINOGEN ACTIVATOR; CEFTRIAXONE; DAPTOMYCIN; LINEZOLID;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; ESOPHAGUS STRICTURE; HUMAN; INTENSIVE CARE; MEDICAL RESEARCH; MEDICAL SOCIETY; META ANALYSIS; MORTALITY; PUBLIC HEALTH; QUALITY OF LIFE; RESPIRATORY DISTRESS SYNDROME; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; ANTIMICROBIAL THERAPY; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG DOSE COMPARISON; INFORMED CONSENT; THERAPY EFFECT; BACTERIAL PNEUMONIA; CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; ECONOMICS; INTENSIVE CARE UNIT; METHODOLOGY; QUALITY ADJUSTED LIFE YEAR; REVIEW; UNITED STATES; VENTILATOR;

CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, BACTERIAL; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES; VENTILATORS, MECHANICAL;

EID: 33846708467     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Carlet J, Ben Ali A, Chalfine A. Epidemiology and control of antibiotic resistance in the intensive care unit. Curr Opin Infect Dis 2004;17(4):309-316.
2. Sterling TR, Ho EJ, Brehm WT, Kirkpatrick MB. Diagnosis and treatment of ventilator-associated pneumonia-impact on survival: a decision analysis. Chest 1996;110(4):1025-1034.
3. Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR. Guidelines for pharmacoeconomic studies: recommendations from the Panel on Cost-Effectiveness in Health and Medicine. Pharmacoeconomics 1997;11(2):159-168.
4. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276(16):1339-1341.
5. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276(15):1253-1258.
6. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276(14):1172-1177.
7. American Thoracic Society. Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research. Am J Respir Crit Care Med 2002;165(4):540-550.
8. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162(2 Pt 1):505-511.
9. Bootman JL, Zaske DE, Wertheimer AI, Rowland C. Cost of individualizing aminoglycoside dosage regimens. Am J Hosp Pharm 1979;36(3):368-370.
10. Bootman JL, Wertheimer AI, Zaske D, Rowland C. Individualizing gentamicin dosage regimens in burn patients with Gram-negative septicemia: a cost-benefit analysis. J Pharm Sci 1979;68(3):267-272.
11. Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332(21):1418-1424.
12. Stal JM, Gregor JC, Preiksaitis HG, Reynolds RP. A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture. Can J Gastroenterol 1998;12(1):43-49.
13. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005;142(5):323-332.
14. Beck EJ, Mandalia S, Gaudreault M, Brewer C, Zowall H, Gilmore N, et al. The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001. AIDS 2004;18(18):2411-2418.
15. Shorr AF. An update on cost-effectiveness analysis in critical care. Curr Opin Crit Care 2002;8(4):337-343.
16. Lefcoe MS, Fox GA, Leasa DJ, Sparrow RK, McCormack DG. Accuracy of portable chest radiography in the critical care setting: diagnosis of pneumonia based on quantitative cultures obtained from protected brush catheter. Chest 1994;105(3):885-887.
17. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003;14(6):523-535.
18. Heyland DK, Kernerman P, Gafni A, Cook DJ. Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit? Crit Care Med 1996;24(9):1591-1598.
19. Carrasco G, Molina R, Costa J, Soler JM, Cabre L. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients: a cost-benefit analysis. Chest 1993;103(2):557-564.
20. Bilen Z, Weinberg PF, Gowani Y, Cohen IL, Socaris S, Fein IA. Clinical utility and cost-effectiveness of protective sleeve pulmonary artery catheters. Crit Care Med 1991;19(4):491-496.
21. Jastremski MS, Chelluri L, Beney KM, Bailly RT. Analysis of the effects of continuous on-line monitoring of mixed venous oxygen saturation on patient outcome and cost-effectiveness. Crit Care Med 1989;17(2):148-153.
22. Inman KJ, Sibbald WJ, Rutledge FS, Clark BJ. Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. JAMA 1993;269(9):1139-1143.
23. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999;159(4 Pt 1):1249-1256.
24. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994;330(6):377-381.
25. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122(6):2115-2121.
26. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274(8):639-644.
27. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995;274(12):968-974.
28. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 1996;154(3 Pt 1):617-624.
29. Rello J, Rue M, Jubert P, Muses G, Sonora R, Valles J, Niederman MS. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997;25(11):1862-1867.
30. Escolano S, Golmard JL, Korinek AM, Mallet A. A multi-state model for evolution of intensive care unit patients: prediction of nosocomial infections and deaths. Stat Med 2000;19(24):3465-3482.
31. Hamel MB, Phillips RS, Davis RB, Teno J, Connors AF, Desbiens N, et al. Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med 2000;109(8):614-620.
32. Lynn J, Knaus WA. Background for SUPPORT. J Clin Epidemiol 1990;43 Suppl:1S-4S.
33. Hlatky MA, Lipscomb J, Nelson C, Califf RM, Pryor D, Wallace AG, Mark DB. Resource use and cost of initial coronary revascularization: coronary angioplasty versus coronary bypass surgery. Circulation 1990;82(5 Suppl):IV208-IV213.
34. Littenberg B, Garber AM, Sox HC Jr. Screening for hypertension. Ann Intern Med 1990;112(3):192-202.